Related Experiment Videos
Elevated levels of soluble interleukin-2 receptors in Crohn's disease
Gastroenterologie Clinique Et Biologique
|January 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Refractory oral manifestations of Crohn's disease.
Journal of stomatology, oral and maxillofacial surgery·2025
Fragmentomic analysis of circulating tumor DNA-targeted cancer panels.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience.
Alimentary pharmacology & therapeutics·2018
[Treatment of chronic hepatitis B: adherence and safety].
Gastroenterologie clinique et biologique·2010
[Long-term therapy for chronic hepatitis B in HIV co-infected patients].
Gastroenterologie clinique et biologique·2010
[Analogs combination therapy in chronic hepatitis B: when and how?].
Gastroenterologie clinique et biologique·2010
[HBsAg seroclearance: prognostic value for the response to treatment and the long-term outcome].
Gastroenterologie clinique et biologique·2010
[HBsAg quantification: virological significance].
Gastroenterologie clinique et biologique·2010
[Influence of treatment on long-term evolution of chronic hepatitis B].
Gastroenterologie clinique et biologique·2010
Indications for Biological Treatment Combined with Allergen-Specific Immunotherapy: Who Is It Really Intended for?
Journal of clinical medicine·2026
Circulating Interleukin-17 Across Airway Disease Phenotypes: A Single-Center Observational Study.
Journal of clinical medicine·2026